Skip to main content

Utah Medical Products Inc

UTMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000706698

No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Utah Medical Products Inc changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of UTMD: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders1121117+6
Shares2.16M5872.17M+9.22K (+0.4%)
Value$122.9M$33.4K$136.5M+$13.6M (+11.1%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Utah Medical Products Inc at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to UTMD in Q3 2025
InstitutionSharesValue% of portfolio
Segall Bryant & Hamill, LLC11,535$726.4K0.01%
Ritholtz Wealth Management5,042$317.5K0.01%
Jane Street Group, LLC3,539$222.9K0.00%
Metis Global Partners, LLC3,447$217.1K0.01%
Wiley Bros.-Aintree Capital, LLC3,400$214.1K0.00%
Advisory Services Network, LLC2,528$159.2K0.00%
SRS Capital Advisors, Inc.881$55.5K0.00%
Meeder Asset Management Inc99$6.23K0.00%
Optiver Holding B.V.34$2.14K0.00%
Farther Finance Advisors, LLC8$5040.00%
Bare Financial Services, Inc8$5040.00%
Clearstead Advisors, LLC3$1890.00%
Rothschild Investment LLC1$630.00%
Sunbelt Securities, Inc.1$630.00%

Sold out (8)

Institutions that held Utah Medical Products Inc at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of UTMD in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Los Angeles Capital Management LLC11,685$665.1K
Citadel Advisors LLC9,367$533.2K
Susquehanna International Group, LLP4,814$274.0K
R Squared Ltd3,679$209.4K
Victory Capital Management Inc2,673$152.1K
Umb Bank N A152$8.65K
Total Investment Management Inc5$292
Bessemer Group Inc1$0

Not filed for Q3 2025 yet (1)

Institutions that held Utah Medical Products Inc at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding UTMD in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
First Horizon Advisors, Inc.587$33.4K